BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 21498351)

  • 1. The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.
    Li TQ; Wahlund LO
    Acta Radiol; 2011 Mar; 52(2):211-22. PubMed ID: 21498351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders.
    Grosskreutz J; Peschel T; Unrath A; Dengler R; Ludolph AC; Kassubek J
    Amyotroph Lateral Scler; 2008 Aug; 9(4):238-48. PubMed ID: 18608107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of novel MRI-based biomarkers for Alzheimer's disease: diffusion tensor imaging and deformation-based morphometry.
    Friese U; Meindl T; Herpertz SC; Reiser MF; Hampel H; Teipel SJ
    J Alzheimers Dis; 2010; 20(2):477-90. PubMed ID: 20164559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies.
    Liu Y; Wang K; Yu C; He Y; Zhou Y; Liang M; Wang L; Jiang T
    Neuropsychologia; 2008; 46(6):1648-56. PubMed ID: 18346763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-based morphometry in Alzheimer's disease.
    Busatto GF; Diniz BS; Zanetti MV
    Expert Rev Neurother; 2008 Nov; 8(11):1691-702. PubMed ID: 18986240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3 Tesla magnetic resonance imaging of the brain. Better morphological and functional images with higher magnetic field strength].
    Larsson EM; Ståhlberg F
    Lakartidningen; 2005 Feb 14-20; 102(7):460-3. PubMed ID: 15768694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional network connectivity breakdown in Alzheimer’s disease studied with magnetic resonance imaging techniques.
    Filippi M; Agosta F
    J Alzheimers Dis; 2011; 24(3):455-74. PubMed ID: 21297259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease.
    Bohanna I; Georgiou-Karistianis N; Hannan AJ; Egan GF
    Brain Res Rev; 2008 Jun; 58(1):209-25. PubMed ID: 18486229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
    Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
    J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research.
    Krishnan S; Talley BD; Slavin MJ; Doraiswamy PM; Petrella JR
    Neuroimaging Clin N Am; 2005 Nov; 15(4):853-68, xi. PubMed ID: 16443496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.
    Kantarci K
    Expert Rev Neurother; 2005 Sep; 5(5):663-70. PubMed ID: 16162090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
    Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
    J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of high-field MRI for studies in Parkinson's disease.
    Schuff N
    Mov Disord; 2009; 24 Suppl 2():S684-90. PubMed ID: 19877239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor MRI to investigate dementias: a brief review.
    Bozzali M; Cherubini A
    Magn Reson Imaging; 2007 Jul; 25(6):969-77. PubMed ID: 17451903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
    Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of voxel-based morphometry with DARTEL and standard registration as imaging biomarkers in Alzheimer's disease patients and cognitively normal older adults at 3.0 Tesla MR imaging.
    Mak HK; Zhang Z; Yau KK; Zhang L; Chan Q; Chu LW
    J Alzheimers Dis; 2011; 23(4):655-64. PubMed ID: 21157022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance approaches to brain aging and Alzheimer disease-associated neuropathology.
    Anderson VC; Litvack ZN; Kaye JA
    Top Magn Reson Imaging; 2005 Dec; 16(6):439-52. PubMed ID: 17088693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.